Valence ロゴ
人気
ログイン

ウォッチリストに追加

Bausch Health Companies I...

Toronto: BHC.TO · リアルタイム株価 · USD
8.82
-0.59 (-6.27%)
終値時点： Aug 21, 2026, 3:59 PM

株価、主要な数字、最新ニュースをひとまとめにしたページです。

Bausch Health Companies Inc.（BHC.TO）の株価・分析・データ

-6.27%
買気配8.83
時価総額3.3B
売上高（TTM）10.85B
純利益（TTM）-1.1B
0.38
-4.06
n/a
1.53
PBR（TTM）-1.35
PSR（TTM）0.30
決算発表日Oct 28, 2026
売気配8.85
出来高2,136,907
平均出来高（20日）657,703
始値9.42
前日終値9.41
当日レンジ8.77 - 9.45
52週レンジ6.10 - 11.08
アナリストn/a
目標株価n/a
配当n/a
権利落ち日2010年11月10日

BHC.TOについて

Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company. It operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The company develops, manufactures, and markets products primarily in the therapeutic areas of gastroenterology, hepatology, neurology and dermatology, generic and branded generic pharmaceuticals, dentistry products, over-the-counter prod...

[続きを読む]
業種 Drug Manufacturers - Specialty & Generic
セクター Healthcare
IPO日 Apr 3, 1996
従業員数 20,300
上場取引所 Toronto
ティッカー BHC.TO
ウェブサイト https://www.bauschhealth.com
企業情報の全文

業績

2025年のBausch Health Companiesの売上高は10.27Bで、前年の9.63Bから6.66%の増加でした。 利益は157Mで、-441.3%の減少でした。

財務数値の通貨はCADです 財務諸表

決算サプライズ

Bausch Health CompaniesはJul 29, 2026に四半期決算を発表しました：
  • 売上高は $2.85B で、予想を下回りました $0, うち 12.73% の前年比増加にあたります.
  • EPSは 1.26 で、予想を上回りました 0.25, うち 38.46% の前年比増加にあたります.

次回決算発表

Bausch Health Companies Inc.の決算発表予定日は Oct 28, 2026, 引け後の予定です。
アナリストの売上高予想は ... アップグレード
news image

1日前 · Zacks

Can Bausch (BHC) Run Higher on Rising Earnings Estimates?

Bausch Health (BHC) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

news image

1日前 · Zacks

Bausch (BHC) Upgraded to Buy: Here's What You Should Know

Bausch (BHC) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

news image

1週間前 · Motley Fool

Why Bausch Health Companies Stock Skyrocketed by Almost 40% Last Month

Much of this was due to a very well-received quarterly earnings report.

news image

3週間前 · Insider Monkey

Bausch Health (BHC) Rockets 28% as Q2 Turnaround Fuels Recovery Outlook

Bausch Health (NYSE:BHC) climbed by 28.85 percent on Thursday to end at $6.03 apiece, after announcing a strong second quarter of the year that set the ground for the company’s profit recovery. In an ...

news image

3週間前 · Zacks

BHC Q2 Earnings Beat Estimates on Salix and Solta Growth, '26 View Raised

BHC beats Q2 estimates as Salix, Solta Medical and Bausch + Lomb fuel growth, lifting 2026 revenue and EBITDA guidance after strong earnings.

2ページ中1ページ